Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKinsey
Dow
Moodys
Mallinckrodt

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR EPIDUO FORTE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Epiduo Forte

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00658112 ↗ Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne Completed Wake Forest University Phase 4 2006-07-01 The purpose of this research study is to see how often benzoyl peroxide is applied for acne. Use of medication was monitored electronically.
NCT00757523 ↗ Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Completed GlaxoSmithKline Phase 4 2008-09-10 The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris
NCT00757523 ↗ Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Completed Stiefel, a GSK Company Phase 4 2008-09-10 The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris
NCT00907101 ↗ Evaluate Effectiveness of Epiduo┬« Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes Completed Galderma Laboratories, L.P. Phase 4 2009-06-01 The purpose of this study is to evaluate the effectiveness of Epiduo┬« Gel in reducing antibiotic sensitive and resistant strains of P acnes in vivo.
NCT00919191 ↗ Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face Completed Bausch Health Americas, Inc. Phase 4 2009-04-01 A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Epiduo Forte

Condition Name

Condition Name for Epiduo Forte
Intervention Trials
Acne Vulgaris 22
Acne 8
Facial Acne 1
Local Adverse Effects 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Epiduo Forte
Intervention Trials
Acne Vulgaris 29
Hypersensitivity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Epiduo Forte

Trials by Country

Trials by Country for Epiduo Forte
Location Trials
United States 63
Canada 7
India 5
Germany 4
Brazil 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Epiduo Forte
Location Trials
North Carolina 6
Texas 6
Florida 5
California 4
Pennsylvania 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Epiduo Forte

Clinical Trial Phase

Clinical Trial Phase for Epiduo Forte
Clinical Trial Phase Trials
Phase 4 15
Phase 3 6
Phase 2 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Epiduo Forte
Clinical Trial Phase Trials
Completed 27
Recruiting 2
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Epiduo Forte

Sponsor Name

Sponsor Name for Epiduo Forte
Sponsor Trials
Galderma Laboratories, L.P. 5
Galderma 5
Galderma R&D 5
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Epiduo Forte
Sponsor Trials
Industry 35
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
McKesson
Boehringer Ingelheim
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.